Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation
Open Access
- 30 April 2010
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (8) , 1358-1365
Abstract
Background Identification of mutations in the SERPINC1 gene has revealed different mechanisms responsible for antithrombin deficiency. Deletions and nonsense mutations associate with type I deficiency. Certain missense mutations cause type II deficiency by affecting the heparin binding site or the reactive center loop, while others result in type I deficiency by intracellular retention or RNA instability. Design and Methods We studied the molecular, biochemical, proteomic and glycomic characterization of a new natural mutant (K241E) that may be classified as pleiotropic. Results The mutation caused a significant decrease in the anticoagulant activity mainly due to a reduced heparin affinity and a modification of the electrostatic potential that might explain the impaired ability of the mutant protein to form complexes with the target protease in the absence of heparin. Mass spectrometry and glycomic analyses confirmed an increased molecular weight of 800 Da in the mutant protein possibly due to core-fucosylation, provoking the loss of heparin affinity. Additionally, carriers of this mutation also have a minor mutant isoform that still followed normal glycosylation, retaining similar heparin affinity to wild-type α-antithrombin, and certain anticoagulant activity, which may explain the milder thrombotic risk of patients carrying this mutation. Similar results were observed using recombinant K241E antithrombin molecules. Conclusions Our data suggest a new mechanism involved in antithrombin type II deficiency by indirectly affecting the glycosylation of a natural variant. Additional studies are required to confirm this hypothesis.Keywords
This publication has 27 references indexed in Scilit:
- Crystal Structure of Monomeric Native Antithrombin Reveals a Novel Reactive Center Loop ConformationJournal of Biological Chemistry, 2006
- Latent antithrombin and its detection, formation and turnover in the circulationJournal of Thrombosis and Haemostasis, 2004
- Mutations in the shutter region of antithrombin result in formation of disulfide‐linked dimers and severe venous thrombosisJournal of Thrombosis and Haemostasis, 2004
- Heparin-induced substrate behavior of antithrombin Cambridge IIBlood, 2003
- Identification of Critical Molecular Interactions Mediating Heparin Activation of Antithrombin Implications for the Design of Improved Heparin AnticoagulantsTrends in Cardiovascular Medicine, 2002
- Electrostatics of nanosystems: Application to microtubules and the ribosomeProceedings of the National Academy of Sciences, 2001
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997
- Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the .beta.-antithrombin III isoform with enhanced heparin affinityBiochemistry, 1995
- Pleiotropic effects of antithrombin strand 1C substitution mutations.Journal of Clinical Investigation, 1992
- Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99FFEBS Letters, 1992